Diferencia entre revisiones de «Thyroid storm»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
== Background == | == Background == | ||
*Mortality | |||
**Without treatment: 80-100% | *Mortality | ||
**Without treatment: 80-100% | |||
**With treatment: 15-50% | **With treatment: 15-50% | ||
===Precipitants=== | === Precipitants === | ||
#Infection | |||
#Trauma | #Infection | ||
#Surgery | #Trauma | ||
#DKA | #Surgery | ||
#Withdrawal of thyroid medication | #DKA | ||
#Iodine administration | #Withdrawal of thyroid medication | ||
#MI | #Iodine administration | ||
#CVA | #MI | ||
#CVA | |||
#PE | #PE | ||
==Diagnosis== | == Diagnosis == | ||
#Classic Triad: | |||
##Hyperthermia | #Classic Triad: | ||
##Tachycardia | ##Hyperthermia | ||
##AMS | ##Tachycardia | ||
###Agitation, confusion, delirium stupor, coma, seizure | ##AMS | ||
#May also have: | ###Agitation, confusion, delirium stupor, coma, seizure | ||
##CHF | #May also have: | ||
##Palpitations | ##CHF | ||
##Dyspnea | ##Palpitations | ||
##Increased pulse pressure | ##Dyspnea | ||
##Increased pulse pressure | |||
##A-fib | ##A-fib | ||
=== Burch & Wartofsky Diagnostic Criteria === | === Burch & Wartofsky Diagnostic Criteria === | ||
'''I. Thermoregulatory dysfunction (Temperature)''' | '''I. Thermoregulatory dysfunction (Temperature)''' | ||
{| border="1" | {| width="300" border="1" cellpadding="1" cellspacing="1" | ||
|- | |||
| Temp | |||
| Points | |||
|- | |- | ||
| 99-99.9 | | 99-99.9 | ||
| Línea 52: | Línea 58: | ||
| 30 | | 30 | ||
|} | |} | ||
'''II. Central nervous system effects''' | '''II. Central nervous system effects''' | ||
| Línea 57: | Línea 64: | ||
{| border="1" | {| border="1" | ||
|- | |- | ||
| Mild (Agitation) | | Mild (Agitation) | ||
| | | 10pts | ||
|- | |- | ||
| Moderate (delirium, psychosis, extreme lethargy) | | Moderate (delirium, psychosis, extreme lethargy) | ||
| | | 20pts | ||
|- | |- | ||
| Severe (seizure, coma) | | Severe (seizure, coma) | ||
| | | 30pts | ||
|} | |} | ||
'''III. Gastrointestinal-hepatic dysfunction''' | '''III. Gastrointestinal-hepatic dysfunction''' | ||
{| border="1" | {| border="1" | ||
|- | |- | ||
| Moderate (diarrhea, n/v, abd pain) | | Moderate (diarrhea, n/v, abd pain) | ||
| | | 10pts | ||
|- | |- | ||
| Severe (unexplained jaundice) | | Severe (unexplained jaundice) | ||
| | | 20pts | ||
|} | |} | ||
'''IV. Cardiovascular dysfunction (tachycardia)''' | '''IV. Cardiovascular dysfunction (tachycardia)''' | ||
{| border="1" | {| border="1" | ||
|- | |- | ||
| 99-109 | | 99-109 | ||
| | | 5pts | ||
|- | |- | ||
| 110-119 | | 110-119 | ||
| | | 10pts | ||
|- | |- | ||
| 120-129 | | 120-129 | ||
| | | 15pts | ||
|- | |- | ||
| 130-139 | | 130-139 | ||
| | | 20pts | ||
|- | |- | ||
| 140 | | 140 | ||
| | | 25pts | ||
|} | |} | ||
'''V. Congestive heart failure''' | '''V. Congestive heart failure''' | ||
{| border="1" | {| border="1" | ||
|- | |- | ||
| Mild (pedal edema) | | Mild (pedal edema) | ||
| | | 5pts | ||
|- | |- | ||
| Moderate (bibasilar rales) | | Moderate (bibasilar rales) | ||
| | | 10pts | ||
|- | |- | ||
| Severe (pulm edema, A. fib) | | Severe (pulm edema, A. fib) | ||
| | | 15pts | ||
|} | |} | ||
'''VI. Precipitant history''' | '''VI. Precipitant history''' | ||
{| border="1" | {| border="1" | ||
|- | |- | ||
| Negative | | Negative | ||
| | | 0pts | ||
|- | |- | ||
| Positive | | Positive | ||
| | | 10pts | ||
|} | |} | ||
'''Scoring''' | '''Scoring''' | ||
* | *>45 = Highly suggestive of thyroid storm | ||
*25-44 = Suggestive of impending storm | *25-44 = Suggestive of impending storm | ||
* | *<25 = Unlikely to represent storm | ||
==DDX== | == DDX == | ||
#Infection | |||
#Sympathomimetic ingestion (cocaine, amphetamine, ketamine) | #Infection | ||
#Heat exhaustion | #Sympathomimetic ingestion (cocaine, amphetamine, ketamine) | ||
#Heat stroke | #Heat exhaustion | ||
#Delirium tremens | #Heat stroke | ||
#Malignant hyperthermia | #Delirium tremens | ||
#Malignant neuroleptic syndrome | #Malignant hyperthermia | ||
#Hypothalamic stroke | #Malignant neuroleptic syndrome | ||
#Pheochromocytoma | #Hypothalamic stroke | ||
#Medication withdrawal (cocaine, opioids) | #Pheochromocytoma | ||
#Psychosis | #Medication withdrawal (cocaine, opioids) | ||
#Psychosis | |||
#Organophosphate poisoning | #Organophosphate poisoning | ||
==Work-Up== | == Work-Up == | ||
*Chemistry | |||
*CBC | *Chemistry | ||
*TSH/Free T3/T4 | *CBC | ||
*Cortisol level (rule-out concurrent adrenal insufficiency) | *TSH/Free T3/T4 | ||
*ECG | *Cortisol level (rule-out concurrent adrenal insufficiency) | ||
*Rule-out infection: | *ECG | ||
**CXR | *Rule-out infection: | ||
**CXR | |||
**Blood culture | **Blood culture | ||
== Treatment == | == Treatment == | ||
#Supportive care | |||
##Fever | #Supportive care | ||
###Cooling measures, acetaminophen (avoid aspirin) | ##Fever | ||
##Dehydration/hypoglycemia | ###Cooling measures, acetaminophen (avoid aspirin) | ||
###D5NS (most pts have depleted glycogen stores) | ##Dehydration/hypoglycemia | ||
##Cardiac decompensation (CHF, A-fib) | ###D5NS (most pts have depleted glycogen stores) | ||
###Rate control, inotropes, diuretics as needed | ##Cardiac decompensation (CHF, A-fib) | ||
#Block new hormone synthesis | ###Rate control, inotropes, diuretics as needed | ||
##PTU 600-1000 mg PO or PR followed by 200-250mg q4hr | #Block new hormone synthesis | ||
###Preferred to methimazole b/c also blocks T4 | ##PTU 600-1000 mg PO or PR followed by 200-250mg q4hr | ||
##Methimazole 20-25mg q4hr | ###Preferred to methimazole b/c also blocks T4>T3 conversion | ||
###Longer acting than PTU | ##Methimazole 20-25mg q4hr | ||
#Block hormone release | ###Longer acting than PTU | ||
##Wolff-Chaikoff effect: incr iodine concentration leads to transient decrease of T3/T4 | #Block hormone release | ||
##Potassium iodide 5 gtt q6hr (Give 1hr after PTU) | ##Wolff-Chaikoff effect: incr iodine concentration leads to transient decrease of T3/T4 | ||
###1st line | ##Potassium iodide 5 gtt q6hr (Give 1hr after PTU) | ||
##Lithium 300mg q6hr | ###1st line | ||
###Consider if iodine allergic | ##Lithium 300mg q6hr | ||
#Block beta-adrenergic tone and peripheral T4 | ###Consider if iodine allergic | ||
##Propranolol PO 60-80 q4hr (if pt can tolerate PO) | #Block beta-adrenergic tone and peripheral T4>T3 conversion | ||
##Propranolol IV 1mg over 10 min; if tolerates then 1-3mg boluses q3hr | ##Propranolol PO 60-80 q4hr (if pt can tolerate PO) | ||
##Esmolol 250-500mcg/kg loading dose, then 50-100mcg/kg/min | ##Propranolol IV 1mg over 10 min; if tolerates then 1-3mg boluses q3hr | ||
#Treat possible adrenal insufficiency (also blocks T4 | ##Esmolol 250-500mcg/kg loading dose, then 50-100mcg/kg/min | ||
#Treat possible adrenal insufficiency (also blocks T4>T3) | |||
##Hydrocortisone 100-300mg IV bolus, followed by 100mg q8hr | ##Hydrocortisone 100-300mg IV bolus, followed by 100mg q8hr | ||
== See Also == | == See Also == | ||
[[Hyperthyroidism]] | |||
[[Hyperthyroidism]] | |||
== Sources == | |||
*Tintinalli | |||
*Tintinalli | *UpToDate | ||
*UpToDate | |||
*Burch, HB, Wartofsky, L, Endocrinol Metab Clin North Am 1993; 22:263 | *Burch, HB, Wartofsky, L, Endocrinol Metab Clin North Am 1993; 22:263 | ||
[[Category:Endo]] | [[Category:Endo]] | ||
Revisión del 02:38 28 sep 2011
Background
- Mortality
- Without treatment: 80-100%
- With treatment: 15-50%
Precipitants
- Infection
- Trauma
- Surgery
- DKA
- Withdrawal of thyroid medication
- Iodine administration
- MI
- CVA
- PE
Diagnosis
- Classic Triad:
- Hyperthermia
- Tachycardia
- AMS
- Agitation, confusion, delirium stupor, coma, seizure
- May also have:
- CHF
- Palpitations
- Dyspnea
- Increased pulse pressure
- A-fib
Burch & Wartofsky Diagnostic Criteria
I. Thermoregulatory dysfunction (Temperature)
| Temp | Points |
| 99-99.9 | 5 |
| 100-100.9 | 10 |
| 101-101.9 | 15 |
| 102-102.9 | 20 |
| 103-103.9 | 25 |
| 104.0 | 30 |
II. Central nervous system effects
| Mild (Agitation) | 10pts |
| Moderate (delirium, psychosis, extreme lethargy) | 20pts |
| Severe (seizure, coma) | 30pts |
III. Gastrointestinal-hepatic dysfunction
| Moderate (diarrhea, n/v, abd pain) | 10pts |
| Severe (unexplained jaundice) | 20pts |
IV. Cardiovascular dysfunction (tachycardia)
| 99-109 | 5pts |
| 110-119 | 10pts |
| 120-129 | 15pts |
| 130-139 | 20pts |
| 140 | 25pts |
V. Congestive heart failure
| Mild (pedal edema) | 5pts |
| Moderate (bibasilar rales) | 10pts |
| Severe (pulm edema, A. fib) | 15pts |
VI. Precipitant history
| Negative | 0pts |
| Positive | 10pts |
Scoring
- >45 = Highly suggestive of thyroid storm
- 25-44 = Suggestive of impending storm
- <25 = Unlikely to represent storm
DDX
- Infection
- Sympathomimetic ingestion (cocaine, amphetamine, ketamine)
- Heat exhaustion
- Heat stroke
- Delirium tremens
- Malignant hyperthermia
- Malignant neuroleptic syndrome
- Hypothalamic stroke
- Pheochromocytoma
- Medication withdrawal (cocaine, opioids)
- Psychosis
- Organophosphate poisoning
Work-Up
- Chemistry
- CBC
- TSH/Free T3/T4
- Cortisol level (rule-out concurrent adrenal insufficiency)
- ECG
- Rule-out infection:
- CXR
- Blood culture
Treatment
- Supportive care
- Fever
- Cooling measures, acetaminophen (avoid aspirin)
- Dehydration/hypoglycemia
- D5NS (most pts have depleted glycogen stores)
- Cardiac decompensation (CHF, A-fib)
- Rate control, inotropes, diuretics as needed
- Fever
- Block new hormone synthesis
- PTU 600-1000 mg PO or PR followed by 200-250mg q4hr
- Preferred to methimazole b/c also blocks T4>T3 conversion
- Methimazole 20-25mg q4hr
- Longer acting than PTU
- PTU 600-1000 mg PO or PR followed by 200-250mg q4hr
- Block hormone release
- Wolff-Chaikoff effect: incr iodine concentration leads to transient decrease of T3/T4
- Potassium iodide 5 gtt q6hr (Give 1hr after PTU)
- 1st line
- Lithium 300mg q6hr
- Consider if iodine allergic
- Block beta-adrenergic tone and peripheral T4>T3 conversion
- Propranolol PO 60-80 q4hr (if pt can tolerate PO)
- Propranolol IV 1mg over 10 min; if tolerates then 1-3mg boluses q3hr
- Esmolol 250-500mcg/kg loading dose, then 50-100mcg/kg/min
- Treat possible adrenal insufficiency (also blocks T4>T3)
- Hydrocortisone 100-300mg IV bolus, followed by 100mg q8hr
See Also
Sources
- Tintinalli
- UpToDate
- Burch, HB, Wartofsky, L, Endocrinol Metab Clin North Am 1993; 22:263
